Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

LeMaitre Vascular launches new stent graft delivery system

LeMaitre Vascular : 19 November, 2007  (New Product)
LeMaitre Vascular has launched the company’s new TT Tortuous Tracker Delivery System, the next-generation system for LeMaitre Vascular's EndoFit and UniFit Aortic Stent Graft product lines.
The new delivery system will be sold in the European Union and other select markets outside of the USA.The TT system is designed to simplify Stent Graft implants by requiring reduced deployment force, providing the physician with increased control over placement of the Stent Graft in the aorta.

The TT system offers better flexibility and an improved coating to increase manoeuvrability through blood vessels and a three-part valve system to minimise blood loss during the medical procedure. The TT system also provides better visualisation during the procedure and a more ergonomic design.

'The TT system should improve the ease of use and therefore the performance of our endovascular Stent grafts,' said Ryan Connelly, director, Research & Development of LeMaitre Vascular. 'Since we acquired our Stent Graft product lines in 2005, we have carefully studied what vascular surgeons need to successfully deliver and deploy aortic Stent grafts. The new TT system gives them what they have been asking for, which will enable better clinical results and improve patients' lives.'

The TT system has already been used by physicians in over a dozen procedures designed to provide the company with pre-launch clinical feedback.

'I was very pleased with the flexibility of the device and its ability to navigate tortuous vessels,' said Thomas Larzon, MD, director of the EndoVascular Unit at Orebro University Hospital in Sweden. 'It took much less physical effort to deploy the Stent graft, which meant that I could more precisely position the Stent Graft where it would provide the best outcome for the patient.'

'We are pleased to be able to offer a delivery system that we believe meets the high performance standards set by our Stent Graft products,' said George W LeMaitre, chairman and CEO of LeMaitre Vascular. 'We believe that the prior generation delivery system had discouraged adoption of our Stent grafts. The TT system removes this impediment to growth.'

The TT system will initially be available in a limited range of sizes as the company scales its production, with all sizes expected to become available by the end of 2008.The TT Tortuous Tracker Delivery System and the EndoFit and UniFit Aortic Stent Grafts are not approved for sale in the USA.
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo